drugset / Trial / NCT01149005
Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate whether insulin treatment during pulmonary exacerbation (PE) in patients with Cystic Fibrosis (CF)and normoglycemia improves their short term outcome by normalizing the glycemic profile and enhancing recovery. the investigators would like to evaluate whether insulin treatment during exacerbation improves both the general clinical condition of these patients and also has a protecting effect on ß-cells by preventing the deleterious effect of "chronic" hyperglycemia.
Timeline
- Start
- 2010-06
- Primary completion
- 2015-06
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin Lispro | Protein / enzyme biologic | 1 iu | Subcutaneous |
| Subject | Insulin Lispro | Protein / enzyme biologic | 4 iu | Subcutaneous |
| Subject | insulin aspart | Protein / enzyme biologic | 1 iu | Subcutaneous |
| Subject | insulin aspart | Protein / enzyme biologic | 4 iu | Subcutaneous |